DISEASE INDICATIONS: Multiple Myeloma

MANUFACTURER: Takeda Pharma A/S

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Therapeutic Goods Administration (TGA)

Ninlaro (ixazomib) is an oral medication used to treat multiple myeloma in combination with other drugs by blocking proteasome activities to promote cancer cell death.